Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 11-12/2006

01.12.2006 | Animal Experimentation

Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole)

verfasst von: Muhammad Fatum, Yi Gyo, Prus Diana, Neri Laufer, Alex Simon

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 11-12/2006

Einloggen, um Zugang zu erhalten

Abstract

Background: Although high levels of estradiol are found in the follicular fluid, little is known about its necessity for adequate follicular growth, oocyte maturation and embryo development. Arimidex (anastrozole) is a potent aromatase inhibitor capable to induce an in-vivo milieu deprived of estradiol. This study uses a mouse model applying Arimidex to create an in-vivo system lacking of estradiol, in order to explore whether this gonadal steroid hormone is mandatory for folliculogenesis followed by normal fertilization and embryo development.
Methods: Experiment 1: Immature C57 Black female mice, aged 3–4 weeks were superovulated by 5 IU PMSG given intraperitoneally. A study group (9 mice) was concomitantly injected with 0.1 mg of Arimidex intraperitoneally given the morning day before PMSG, the morning day of PMSG injection and the following two days. The control group (8 mice) was similarly injected with normal saline. Estradiol (E2) and progesterone (P) serum levels were tested 48 hours after PMSG and the ovaries of each mouse blindly examined by a pathologist to evaluate follicular development. Experiment 2: 48 h after PMSG superovulation, hCG (7.5 IU) was injected intraperitoneally, followed by mating. The study group was treated with Arimidex 0.1 mg intraperitoneally daily from a day prior to PMSG injection to the day of sacrifice. The control group was treated similarly by normal saline. Forty-two hours after mating blood was withdrawn for E2 and P levels followed by tubal dissection. Embryos of 2–4 cells were cultured in-vitro and the development to the morula, blastocyst and hatching blastocyst stages were examined 24, 42, and 48 h later.
Results: Experiment 1: A significant reduction of E2 levels was achieved in the Arimidex group in comparison to control group (126.3±104.8 and 1910±960 pmol/L, respectively; < 0.0001). Nevertheless, the two groups did not differ by the mean number of follicles (27±9.5 and 30.4±13.0) or the distribution for antral (65% and 68.4%) and pre-antral (35% and 31.6%) follicles, respectively. Experiment 2: The reduction of estradiol during follicular phase did not hamper follicular development, in-vivo fertilization and in-vitro embryo development. Similar rates of embryo development to the morula stage (90.6% and 86%), blastocyst stage (86% and 89%) and hatching blastocyst (81% and 78%) were achieved in the Arimidex group and the control group, respectively.
Conclusions: Adequate folliculogenesis is independent of estrogen but is conditioned on gonadotropin stimulation. Moreover, depletion of estradiol in the vicinity of the oocyte did not impair its developmental potential, including its fertilization and development into morulae, blastocysts and hatching blastocysts.
Literatur
1.
Zurück zum Zitat Hillier SG. Ovarian manipulation with pure gonadotropins. J Endocrinol 1990;127:1–4.PubMed Hillier SG. Ovarian manipulation with pure gonadotropins. J Endocrinol 1990;127:1–4.PubMed
2.
Zurück zum Zitat Wu TC, Wang L, Wan YJ. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril 1993;59:54–9.PubMed Wu TC, Wang L, Wan YJ. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril 1993;59:54–9.PubMed
3.
Zurück zum Zitat Couse JF, Lindzey, Grandrian K, Gustafsson JA, Korach KS. Tissue distribution and quanitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild wild type and ER-α knockout mouse. Endocrinollogy 1997;138:4613–21. Couse JF, Lindzey, Grandrian K, Gustafsson JA, Korach KS. Tissue distribution and quanitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild wild type and ER-α knockout mouse. Endocrinollogy 1997;138:4613–21.
4.
Zurück zum Zitat Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V. Cloning, chromosomal localization and function analysis of the murine estrogen receptor B. Mol Endocrinol 1997;11:353–65.PubMedCrossRef Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V. Cloning, chromosomal localization and function analysis of the murine estrogen receptor B. Mol Endocrinol 1997;11:353–65.PubMedCrossRef
5.
Zurück zum Zitat Dukes M, Edwards PN, Large M, Smith IK, Boyle T. The preclinical pharmacology of “Arimidex” (Anastrozole;ZD1033)- a potent, selective aromatase inhibitor. J Steroid Biochem Molec Biol 1996;58:439–45.PubMedCrossRef Dukes M, Edwards PN, Large M, Smith IK, Boyle T. The preclinical pharmacology of “Arimidex” (Anastrozole;ZD1033)- a potent, selective aromatase inhibitor. J Steroid Biochem Molec Biol 1996;58:439–45.PubMedCrossRef
6.
Zurück zum Zitat Meirow D, Schenker JG, Rosler A. Ovarian hyperstimulation syndrome with low estradiol in non-classical 17 alpha-hydroxylase 17, 20-lyase deficiency: what is the role of estrogens? Hum Reprod 1996;11:2119–21.PubMed Meirow D, Schenker JG, Rosler A. Ovarian hyperstimulation syndrome with low estradiol in non-classical 17 alpha-hydroxylase 17, 20-lyase deficiency: what is the role of estrogens? Hum Reprod 1996;11:2119–21.PubMed
7.
Zurück zum Zitat Pellicer A, Miro F, Sampaio M, Gomez E, Bonilla-Musoles FM. In-vitro fertilization as a diagnostic and therapeutic tool in a patient with 17, 20-desmolase deficiency. Fertil Steril 1991;55:970–5.PubMed Pellicer A, Miro F, Sampaio M, Gomez E, Bonilla-Musoles FM. In-vitro fertilization as a diagnostic and therapeutic tool in a patient with 17, 20-desmolase deficiency. Fertil Steril 1991;55:970–5.PubMed
8.
Zurück zum Zitat Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente C, Geier A, Lunenfeld B, Mashiach S. In-vitro fertilization and primary embryonic cleavage are possible in 17 alpha hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Cl Endocrinol Metabol 1989;68:693–7.CrossRef Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente C, Geier A, Lunenfeld B, Mashiach S. In-vitro fertilization and primary embryonic cleavage are possible in 17 alpha hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Cl Endocrinol Metabol 1989;68:693–7.CrossRef
9.
Zurück zum Zitat Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpso ER. A syndrome of female pseudohermaphordism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (p450arom). J Clin Endocrinol Metab 1994;78:1287–92.PubMedCrossRef Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpso ER. A syndrome of female pseudohermaphordism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (p450arom). J Clin Endocrinol Metab 1994;78:1287–92.PubMedCrossRef
10.
Zurück zum Zitat Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Cl Endocrinol Metab 1995;80:3689–98.CrossRef Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Cl Endocrinol Metab 1995;80:3689–98.CrossRef
11.
Zurück zum Zitat Rosenfeld CS, Murray AA, Simmer G, Hufford MG, Smith MF, Spears N, Lubahn DB. Gonadotropin induction of ovulation and corpus loteum formation in young estrogen receptor-knockout mice. Biolo Reprod 2000;62:599–605.CrossRef Rosenfeld CS, Murray AA, Simmer G, Hufford MG, Smith MF, Spears N, Lubahn DB. Gonadotropin induction of ovulation and corpus loteum formation in young estrogen receptor-knockout mice. Biolo Reprod 2000;62:599–605.CrossRef
12.
Zurück zum Zitat Krege JH, Hodgin JB, Couse JF, Enmark E, Warne M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. Generation of reproductive phenotypes of mice lacking estrogen receptor-beta. Proc Natl Acad Sci USA 1998;95:15677–82.PubMedCrossRef Krege JH, Hodgin JB, Couse JF, Enmark E, Warne M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. Generation of reproductive phenotypes of mice lacking estrogen receptor-beta. Proc Natl Acad Sci USA 1998;95:15677–82.PubMedCrossRef
13.
Zurück zum Zitat Selvaraj N, Shetty G, Vijayalakshmi K, Bhatnagar AS, Moudgal NR. Effect of blocking oestrogen synthesis with a new generation aromatase inhibitor CGS 16949A on folliculr maturation induced by pregnant mare serum gonadotropin in the immature rat. J Endocrinol 1994;142:563–70.PubMedCrossRef Selvaraj N, Shetty G, Vijayalakshmi K, Bhatnagar AS, Moudgal NR. Effect of blocking oestrogen synthesis with a new generation aromatase inhibitor CGS 16949A on folliculr maturation induced by pregnant mare serum gonadotropin in the immature rat. J Endocrinol 1994;142:563–70.PubMedCrossRef
14.
Zurück zum Zitat Zelinski-Wooten MB, Hess DL, Baughman WL, Molskness TA, Wolf DP, Stouffer RL. Administrasion of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicular development, oocyte maturation, and subsequent luteal function. J Clin Endocrinol Metabol 1993;76:988–95.CrossRef Zelinski-Wooten MB, Hess DL, Baughman WL, Molskness TA, Wolf DP, Stouffer RL. Administrasion of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicular development, oocyte maturation, and subsequent luteal function. J Clin Endocrinol Metabol 1993;76:988–95.CrossRef
15.
Zurück zum Zitat Moudgal NR, Shetty G, Selvaraj N, Bhatnagar AS. Use of sepecific aromatase inhibitor for determining wether there is a role for oestrogen in follicle/oocyte maturation, ovulation and preimplantation embryo development. J Reprod Fertil Suppl 1996;50:69–81.PubMed Moudgal NR, Shetty G, Selvaraj N, Bhatnagar AS. Use of sepecific aromatase inhibitor for determining wether there is a role for oestrogen in follicle/oocyte maturation, ovulation and preimplantation embryo development. J Reprod Fertil Suppl 1996;50:69–81.PubMed
16.
Zurück zum Zitat Hu, Y, Cortrrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev 2002;61:549–59.PubMedCrossRef Hu, Y, Cortrrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev 2002;61:549–59.PubMedCrossRef
17.
Zurück zum Zitat Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 1998;95:6965–70.PubMedCrossRef Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 1998;95:6965–70.PubMedCrossRef
18.
Zurück zum Zitat Britt KL, Drummond AE, Cox VA, Dyson M, Wreford NG, Jones ME, Simpson ER, Findlay JK. An age related ovarian phenotype in mice with targeted disruption of the Cyp19 (aromatase) gene. Endocrinology 2000;141:2614–23.PubMedCrossRef Britt KL, Drummond AE, Cox VA, Dyson M, Wreford NG, Jones ME, Simpson ER, Findlay JK. An age related ovarian phenotype in mice with targeted disruption of the Cyp19 (aromatase) gene. Endocrinology 2000;141:2614–23.PubMedCrossRef
Metadaten
Titel
Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole)
verfasst von
Muhammad Fatum
Yi Gyo
Prus Diana
Neri Laufer
Alex Simon
Publikationsdatum
01.12.2006
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 11-12/2006
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-006-9089-2

Weitere Artikel der Ausgabe 11-12/2006

Journal of Assisted Reproduction and Genetics 11-12/2006 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.